AIM
Aim Immunotech
$0.16
−$0.00 (−2.42%)Oct 29, 2026
Key metrics
The numbers that frame AIM today
- Market cap
- $4.90M
- Gross margin
- -23.2%
- ROIC
- 4,516.6%
- Div yield
- 0%
- Debt / equity
- 0.5
- 52wk Low
- $0.15
- 52wk High
- $2.62
Growth
Revenue and earnings trend for AIM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AIM
Is Aim Immunotech a good buy?
No. Aim Immunotech has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case.
What is the market capitalization of AIM?
Aim Immunotech's market capitalization is $4.90M.
What is the 52-week high for AIM stock?
The 52-week high for Aim Immunotech is $2.62. The current close of $0.16 is 93.9% below that high.
What is the 52-week low for AIM stock?
The 52-week low for Aim Immunotech is $0.15. The current close of $0.16 is 7.3% above that low.
Does AIM stock pay dividends?
Aim Immunotech does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AIM?
Aim Immunotech's Debt / Equity ratio is 0.51.